ライブ

CellExpansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy Endpoints NewsBiopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and more Science Daily BiotechThe secret language behind animal cooperation Endpoints NewsEndpoints News History: 10 Years, Bootstrap to FT Clinical OMICsImproving HSV-2 Vaccine Efficacy with Combination Strategy CellMultimodal imaging of gene expression, morphology, and activity of the same neuron 10x Genomics News10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics - Zacks Investment Research FierceBiotechFDA warning slams Zoll Medical with multiple quality control and reporting violations BioWorldHangzhou Innogate Pharma discovers new KAT inhibitors BioWorldAlicorn synthesizes new AAK1 inhibitors BioWorldChinese scientists identify new macrocyclic compounds as kinase inhibitors BioWorldNew VAV1 degradation inducers reported in Haisco Pharmaceutical Group patents

アーカイブ

最新古い順クリア

合計 80

ページ 5 / 5

検索 --

FierceBiotech 2025年12月9日

ASH: Novartis details ianalumab's phase 3 win in rare blood disease

BioPharma Dive 2025年12月9日

FDA raises CAR-T approval standards; Novartis bets on an AI startup

FierceBiotech 2025年12月9日

Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech

Endpoints News 2025年12月8日

#ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?

BioPharma Dive 2025年12月8日

Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment

BioPharma Dive 2025年11月26日

Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3

BioPharma Dive 2025年11月25日

Novartis wins approval to use SMA gene therapy in older patients

Novartis 2025年8月21日

Novartis in San Diego: A Quarter Century of R&D Innovation - Novartis